{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:07:51Z","timestamp":1773277671885,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T00:00:00Z","timestamp":1481500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH","award":["R01-AI071163"],"award-info":[{"award-number":["R01-AI071163"]}]},{"name":"NIH","award":["P01-HL053749"],"award-info":[{"award-number":["P01-HL053749"]}]},{"name":"NIH","award":["P01-AI097100"],"award-info":[{"award-number":["P01-AI097100"]}]},{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Seattle Children\u2019s Hospital Program for Cell and Gene Therapy"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.omtm.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T15:04:44Z","timestamp":1482073484000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector"],"prefix":"10.1016","volume":"4","author":[{"given":"Swati","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iram","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socheath","family":"Khim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Wielgosz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Norgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Adair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denny","family":"Liggitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Nienhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Rawlings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2016.11.001_bib1","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","article-title":"Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome","volume":"113","author":"Bosticardo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev.med.56.090203.104142","article-title":"Gene therapy for severe combined immunodeficiency","volume":"56","author":"Cavazzana-Calvo","year":"2005","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omtm.2016.11.001_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MOH.0b013e3282f30448","article-title":"Wiskott-Aldrich syndrome","volume":"15","author":"Notarangelo","year":"2008","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.omtm.2016.11.001_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","article-title":"The Wiskott-Aldrich syndrome","volume":"117","author":"Ochs","year":"2006","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2016.11.001_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/ACI.0b013e32834c230c","article-title":"Gene therapy for the Wiskott-Aldrich syndrome","volume":"11","author":"Galy","year":"2011","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2016.11.001_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.moh.0000168520.98990.19","article-title":"Structure and function of the Wiskott-Aldrich syndrome protein","volume":"12","author":"Ochs","year":"2005","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.omtm.2016.11.001_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nri2724","article-title":"WASP: a key immunological multitasker","volume":"10","author":"Thrasher","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtm.2016.11.001_bib8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2009.31","article-title":"Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models","volume":"17","author":"Marangoni","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2016.11.001_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood-2007-03-076679","article-title":"Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation","volume":"111","author":"Ozsahin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib10","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2016.11.001_bib11","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2016.11.001_bib12","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jama.2015.3253","article-title":"Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome","volume":"313","author":"Hacein-Bey Abina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2016.11.001_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T\u00a0cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.omtm.2016.11.001_bib14","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2016.11.001_bib15","doi-asserted-by":"crossref","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2016.11.001_bib16","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1371\/journal.pbio.0020234","article-title":"Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences","volume":"2","author":"Mitchell","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omtm.2016.11.001_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","article-title":"HIV-1 integration in the human genome favors active genes and local hotspots","volume":"110","author":"Schr\u00f6der","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2016.11.001_bib18","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.1083413","article-title":"Transcription start regions in the human genome are favored targets for MLV integration","volume":"300","author":"Wu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.omtm.2016.11.001_bib19","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/mt.2009.179","article-title":"Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors","volume":"17","author":"Modlich","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2016.11.001_bib20","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1182\/blood-2011-03-340711","article-title":"Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome","volume":"119","author":"Astrakhan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib21","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20110200","article-title":"WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity","volume":"208","author":"Becker-Herman","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2016.11.001_bib22","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.1400098","article-title":"Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation","volume":"192","author":"Jackson","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2016.11.001_bib23","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2011-09-379412","article-title":"B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice","volume":"119","author":"Recher","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jaci.2015.01.035","article-title":"B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome","volume":"136","author":"Castiello","year":"2015","journal-title":"J\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2016.11.001_bib25","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1172\/JCI82249","article-title":"Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients","volume":"125","author":"Pala","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2016.11.001_bib26","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JVI.69.2.748-755.1995","article-title":"Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells","volume":"69","author":"Challita","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2016.11.001_bib27","doi-asserted-by":"crossref","first-page":"14063","DOI":"10.1038\/mtm.2014.63","article-title":"Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy","volume":"2","author":"Wielgosz","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2016.11.001_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/humc.2012.244","article-title":"Comparison of insulators and promoters for expression of the Wiskott-Aldrich syndrome protein using lentiviral vectors","volume":"24","author":"Koldej","year":"2013","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtm.2016.11.001_bib29","first-page":"255","article-title":"[Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector]","volume":"194","author":"Cartier","year":"2010","journal-title":"Bull. Acad Natl. Med."},{"key":"10.1016\/j.omtm.2016.11.001_bib30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/mt.2014.3","article-title":"Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in\u00a0vivo","volume":"22","author":"Cesana","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2016.11.001_bib31","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1182\/blood-2007-04-085506","article-title":"An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation","volume":"111","author":"Ryu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1101\/sqb.2004.69.245","article-title":"Chromatin boundaries and chromatin domains","volume":"69","author":"Felsenfeld","year":"2004","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.omtm.2016.11.001_bib33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrg1925","article-title":"Insulators: exploiting transcriptional and epigenetic mechanisms","volume":"7","author":"Gaszner","year":"2006","journal-title":"Nat. Rev. Genet."},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2016.11.001_bib34","first-page":"265","article-title":"Stem cell gene therapy, position effects and chromatin insulators","volume":"15","author":"Neff","year":"1997","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtm.2016.11.001_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/hum.2010.233","article-title":"The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors","volume":"22","author":"Emery","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2016.11.001_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrg2765","article-title":"Insulators and promoters: closer than we think","volume":"11","author":"Raab","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtm.2016.11.001_bib37","doi-asserted-by":"crossref","first-page":"e6995","DOI":"10.1371\/journal.pone.0006995","article-title":"The 3\u2032 region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity","volume":"4","author":"Arumugam","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2016.11.001_bib38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/mt.2016.55","article-title":"Evaluating the safety of retroviral vectors based on insertional oncogene activation and blocked differentiation in cultured thymocytes","volume":"24","author":"Zhou","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2016.11.001_bib39","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.4049\/jimmunol.0804256","article-title":"Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells","volume":"182","author":"Astrakhan","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2016.11.001_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI29539","article-title":"Wiskott-Aldrich syndrome protein is required for regulatory T\u00a0cell homeostasis","volume":"117","author":"Humblet-Baron","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2016.11.001_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1074-7613(00)80590-7","article-title":"Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation","volume":"9","author":"Snapper","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.omtm.2016.11.001_bib42","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1084\/jem.190.9.1329","article-title":"Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes","volume":"190","author":"Zhang","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2016.11.001_bib43","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/eji.201545644","article-title":"B-cell intrinsic TLR7 signals promote depletion of the marginal zone in a murine model of Wiskott-Aldrich syndrome","volume":"45","author":"Kolhatkar","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtm.2016.11.001_bib44","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood-2004-03-1003","article-title":"Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response","volume":"105","author":"Westerberg","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib45","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/leu.2008.118","article-title":"Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16","volume":"22","author":"Modlich","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.omtm.2016.11.001_bib46","doi-asserted-by":"crossref","first-page":"e62333","DOI":"10.1371\/journal.pone.0062333","article-title":"Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vector","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2016.11.001_bib47","doi-asserted-by":"crossref","first-page":"14055","DOI":"10.1038\/mtm.2014.55","article-title":"Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathies","volume":"1","author":"Kiem","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2016.11.001_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-4939-1133-2_22","article-title":"High-throughput genomic mapping of vector integration sites in gene therapy studies","volume":"1185","author":"Beard","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2016.11.001_bib49","doi-asserted-by":"crossref","first-page":"D670","DOI":"10.1093\/nar\/gku1177","article-title":"The UCSC Genome Browser database: 2015 update","volume":"43","author":"Rosenbloom","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2016.11.001_bib50","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2016.11.001_bib51","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood-2002-07-2099","article-title":"A defect in hematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome","volume":"102","author":"Lacout","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib52","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2007-02-075382","article-title":"Hematopoietic stem-cell behavior in nonhuman primates","volume":"110","author":"Shepherd","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib53","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/gt.2010.47","article-title":"Large animal models of hematopoietic stem cell gene therapy","volume":"17","author":"Trobridge","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2016.11.001_bib54","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/mt.2014.95","article-title":"Charting a clear path: the ASGCT Standardized Pathways Conference","volume":"22","author":"Kiem","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2016.11.001_bib55","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood-2004-01-0045","article-title":"Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system","volume":"103","author":"Hanawa","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib56","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/mt.2009.1","article-title":"Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element","volume":"17","author":"Hanawa","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2016.11.001_bib57","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood.V91.12.4554","article-title":"A 5\u2032 regulatory sequence containing two Ets motifs controls the expression of the Wiskott-Aldrich syndrome protein (WASP) gene in human hematopoietic cells","volume":"91","author":"Petrella","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib58","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/mthe.2002.0549","article-title":"Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood","volume":"5","author":"Hanawa","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2016.11.001_bib59","doi-asserted-by":"crossref","first-page":"8410","DOI":"10.1128\/JVI.79.13.8410-8421.2005","article-title":"Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors","volume":"79","author":"Hanawa","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2016.11.001_bib60","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood-2009-09-241869","article-title":"B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia","volume":"115","author":"Kerns","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2016.11.001_bib61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/mt.2010.259","article-title":"Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B cell disorders","volume":"19","author":"Sather","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2016.11.001_bib62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12859-015-0653-6","article-title":"VISA--Vector Integration Site Analysis server: a web-based server to rapidly identify retroviral integration sites from next-generation sequencing","volume":"16","author":"Hocum","year":"2015","journal-title":"BMC Bioinformatics"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050116301292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050116301292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T01:51:35Z","timestamp":1601257895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050116301292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":62,"alternative-id":["S2329050116301292"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2016.11.001","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors.","name":"copyright","label":"Copyright"}]}}